Phibro Animal Health CorporationPAHCNASDAQ
Loading
Free Cash Flow Growth Recovery in ProgressRecovering
Percentile Rank77
3Y CAGR+64.5%
5Y CAGR-8.5%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
+64.5%/yr
Quarterly compound
5Y CAGR
-8.5%/yr
Recent acceleration
Percentile
P77
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 283.28% |
| Q3 2025 | -155.40% |
| Q2 2025 | -77.04% |
| Q1 2025 | 846.06% |
| Q4 2024 | -256.17% |
| Q3 2024 | -80.21% |
| Q2 2024 | 815.74% |
| Q1 2024 | -91.86% |
| Q4 2023 | 136.15% |
| Q3 2023 | -6.68% |
| Q2 2023 | 666.83% |
| Q1 2023 | 86.60% |
| Q4 2022 | 63.67% |
| Q3 2022 | -228.36% |
| Q2 2022 | -165.67% |
| Q1 2022 | -131.23% |
| Q4 2021 | 442.67% |
| Q3 2021 | 9.84% |
| Q2 2021 | -144.04% |
| Q1 2021 | -53.37% |
| Q4 2020 | 442.45% |
| Q3 2020 | 7.69% |
| Q2 2020 | -132.46% |
| Q1 2020 | -19.26% |
| Q4 2019 | 310.32% |
| Q3 2019 | -336.14% |
| Q2 2019 | -40.45% |
| Q1 2019 | -13.90% |
| Q4 2018 | 294.76% |
| Q3 2018 | -204.13% |
| Q2 2018 | -75.43% |
| Q1 2018 | -34.46% |
| Q4 2017 | 14683.08% |
| Q3 2017 | -102.41% |
| Q2 2017 | -74.89% |
| Q1 2017 | 49.20% |
| Q4 2016 | 39.11% |
| Q3 2016 | -17.70% |
| Q2 2016 | 416.22% |
| Q1 2016 | -282.64% |